Leerink Partners Keeps Their Buy Rating on Tandem Diabetes Care (TNDM)
Leerink Partners analyst Mike Kratky maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) on November 25 and set a price ...
Armed robbery in Revesby4d
Otago Researchers Secure $2.8M Funding Boost
Sixteen University of Otago – Ōtākou Whakaihu Waka researchers have received $2.8 million of Health Research Council funding ...
FierceBiotech5d
Embecta shutters newly cleared insulin patch pump program amid layoffs, restructuring
Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now ...
Medscape3d
Insulin Pump Risks and Benefits
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.
Benzinga.com5d
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
The Becton, Dickinson and Company BDX spin-off announced that it decided to discontinue its insulin patch pump program and plans to initiate a restructuring plan. In July, Embecta, a manufacturer ...
Yahoo Finance2d
Insulet Corporation (PODD)
ACTON, Mass., November 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today ...
No 'one size fits all' treatment for type 1 diabetes, study finds
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery ...
Science Daily5d
No 'one size fits all' treatment for Type 1 Diabetes
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study ...
News Medical on MSN6d
New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes
A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...
Yahoo Finance2d
Insulet Corporation (PODD)
ACTON, Mass., November 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today ...
pharmaphorum2d
Oral insulin could still be a reality, says Novo Nordisk
Other companies are looking to administer insulin with needle-free devices, and insulin pumps, which also make therapy more convenient, are already gaining in popularity. Novo Nordisk is investing ...
medtechdive6d
Embecta discontinues insulin patch pump development
Embecta said Tuesday that it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The Parsippany, New ...